Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ryoyama

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamideK Ryoyama
Journal of Submicroscopic Cytology and Pathology|April 1, 1991
Further cytological observation on 'activation' by superimposed antigen of inflammation-mediated macrophagesI Hori, K Ryoyama
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Cyclophosphamide modifies the induction kinetics but not cell types and cytotoxic mechanisms of antitumor cells elicited with OK-432 plus attenuated tumor cellsK Ryoyama, C Ryoyama
The Japanese Journal of Experimental Medicine|October 1, 1987
Appearance of a helper activity by mouse serum in cultured lymphoid cellsK Ryoyama, C Ryoyama
Cancer Treatment Reports|January 1, 1977
Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432S Koshimura, K Ryoyama
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serumC Ryoyama, K Ryoyama
Journal of Morphology|August 1, 1990
Cell surface changes of in situ macrophages induced by superimposed antigenI Hori, K Ryoyama
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the hostK Ryoyama, C Ryoyama
Cancer Immunology, Immunotherapy : CII|November 1, 1993
Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitorsK Ryoyama, T Nomura, S Nakamura
Gan|February 1, 1979
Effect of OK-432 on immunization with mitomycin-C-treated L1210 cellsK Ryoyama, T Murayama, S Koshimura
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamideK Ryoyama
Journal of Submicroscopic Cytology and Pathology|April 1, 1991
Further cytological observation on 'activation' by superimposed antigen of inflammation-mediated macrophagesI Hori, K Ryoyama
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Cyclophosphamide modifies the induction kinetics but not cell types and cytotoxic mechanisms of antitumor cells elicited with OK-432 plus attenuated tumor cellsK Ryoyama, C Ryoyama
The Japanese Journal of Experimental Medicine|October 1, 1987
Appearance of a helper activity by mouse serum in cultured lymphoid cellsK Ryoyama, C Ryoyama
Cancer Treatment Reports|January 1, 1977
Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432S Koshimura, K Ryoyama
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serumC Ryoyama, K Ryoyama
Journal of Morphology|August 1, 1990
Cell surface changes of in situ macrophages induced by superimposed antigenI Hori, K Ryoyama
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the hostK Ryoyama, C Ryoyama
Cancer Immunology, Immunotherapy : CII|November 1, 1993
Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitorsK Ryoyama, T Nomura, S Nakamura
Gan|February 1, 1979
Effect of OK-432 on immunization with mitomycin-C-treated L1210 cellsK Ryoyama, T Murayama, S Koshimura
Pageof 4